"The Point"
The Exchange of Scientific Information During COVID-19, Part 2: Content
By Mark Schoeman One of Clear Point Health’s core lines of business is engaging key opinion leaders (KOLs) on behalf of pharmaceutical companies, to glean
The Exchange of Scientific Information During COVID-19, Part 1: Channel
By Mark Schoeman At this point, in the midst of a global pandemic, both medical science liaisons (MSLs) and commercial sales representatives are virtually unable
The Emerging Case for Patient Engagement
By Sima Marzban, MD, PhD, MPH The relationships between patients and healthcare providers and intermediaries (healthcare providers, manufacturers, and insurers) have been transformed in recent
Clear Points | Episode One: Let’s Get Digital
Episode One: Let’s Get Digital A conversation featuring Paul Meade, founder of Clear Point Health and a faculty member at the UNC Gillings School of
Virtual Engagement: The New Normal of Video Conferencing
By Paul Meade Long gone are the days when you could walk into a medical practice, and get a ten-minute meeting with a physician to
The Rise of Virtual Engagement
By Mark Schoeman When this pandemic began, we understood that it was going to have a significant impact on the pharmaceutical industry, but we’re just
